The efficacy and tolerability of doxycycline and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan

被引:24
作者
Sonmez, A [1 ]
Harlak, A
Kilic, S
Polat, Z
Hayat, L
Keskin, O
Dogru, T
Yilmaz, MI
Acikel, CH
Kocar, IH
机构
[1] Gulhane Sch Med, Dept Internal Med, Gen Tevfik Saglam Caddesi, TR-06018 Ankara, Turkey
[2] Mil Hosp, Serv Gen Surg, Isparta, Turkey
[3] Gulhane Sch Med, Dept Epidemiol, TR-06018 Ankara, Turkey
[4] Gulhane Sch Med, Dept Gastroenterol, TR-06018 Ankara, Turkey
[5] Mil Hosp, Infect Dis Serv, Manisa, Turkey
[6] Gata Haydarpasa Training Hosp, Dept Emergency Med, Istanbul, Turkey
[7] Gulhane Sch Med, Dept Nephrol, TR-06018 Ankara, Turkey
关键词
malaria; chemoprophylaxis; doxycycline; mefloquine; tolerability; compliance; efficacy;
D O I
10.1016/j.jinf.2005.01.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives. Afghanistan is one of the endemic regions of chloroquine resistant P. falciparum. Mefloquine and doxycycline are among the recommended prophylactic regimes. The aim of the study was to compare the efficacy and tolerability of the two regimes on the Turkish soldiers settled in Kabul, Afghanistan. Methods. A total number of 1400 soldiers were subjected to prophylactic regimes with either doxycycline 100 mg/day (n = 986) or mefloquine 250 mg/week (n = 414). Prophylaxis lasted about 12 weeks. The side effects and compliances were investigated by questionnaires. All soldiers were monitored up to 6 months after returning home. Results. No malaria case was observed and there was no severe side effect in either group. The total side effects in doxycycline group were significantly higher (P < 0.001). The compliance of mefloquine takers was better than the doxycycline takers (P < 0.05). Conclusions. The tolerability of the mefloquine regime is better than the doxycycline regime in malaria prophylaxis. (c) 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 14 条
[1]  
BERN JL, 1992, J TROP MED HYG, V95, P167
[2]  
*CDC, 2003, YELL BOOK HLTH INF I
[3]  
Epstein J. E., 2000, Current Treatment Options in Infectious Diseases, V2, P259
[4]   Tolerance of mefloquine chemoprophylaxis in Dutch military personnel [J].
Jaspers, CAJJ ;
Buma, APCCH ;
vanThiel, PPAM ;
vanHulst, RA ;
Kager, PA .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 55 (02) :230-234
[5]   Disease and dislocation: the impact of refugee movements on the geography of malaria in NWFP, Pakistan [J].
Kazmi, JH ;
Pandit, K .
SOCIAL SCIENCE & MEDICINE, 2001, 52 (07) :1043-1055
[6]  
MARK RW, 2002, CLIN INFECT DIS, V34, pS171
[7]   Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers - A randomized, double-blind, placebo-controlled trial [J].
Ohrt, C ;
Richie, TL ;
Widjaja, H ;
Shanks, D ;
Fitriadi, J ;
Fryauff, DJ ;
Handschin, J ;
Tang, D ;
Sandjaja, B ;
Tjitra, E ;
Hadiarso, L ;
Watt, G ;
Wignall, FS .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :963-972
[8]  
Rab MA, 2001, ANN TROP MED PARASIT, V95, P41, DOI 10.1080/00034980020035906
[9]   Malaria control in Afghan refugee camps: novel solutions [J].
Rowland, M .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (02) :125-126
[10]   Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study [J].
Schlagenhauf, P ;
Tschopp, A ;
Johnson, R ;
Nothdurft, HD ;
Beck, B ;
Schwartz, E ;
Herold, M ;
Krebs, B ;
Veit, O ;
Allwinn, R ;
Steffen, R .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7423) :1078-+